Rohan Palekar

This profile gathers the share dealings of Rohan Palekar across 3 companies, led by 89bio, Inc., Medivation, Inc. and Avanir Pharmaceuticals. We count 74 filings; the first trade dates from 14 January 2008 and the latest from 30 October 2025.

On the open market, the record shows 9 purchases worth €334k and 17 sales worth €3.5M. Taken together, the sales exceed the purchases by €3.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 37 share grants and 10 option exercises.

Half of the purchases are above €31k and half below. Of 6 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 30 October 2025: a transaction, in 89bio, Inc. The last insider purchase was made public on 10 December 2024, 683 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.